Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Corvus Pharmaceuticals (CRVS) Return on Assets (2022 - 2025)

Corvus Pharmaceuticals has reported Return on Assets over the past 4 years, most recently at 0.14% for Q3 2025.

  • Quarterly results put Return on Assets at 0.14% for Q3 2025, up 74.0% from a year ago — trailing twelve months through Sep 2025 was 0.14% (up 74.0% YoY), and the annual figure for FY2024 was 1.03%, down 65.0%.
  • Return on Assets for Q3 2025 was 0.14% at Corvus Pharmaceuticals, up from 0.56% in the prior quarter.
  • Over the last five years, Return on Assets for CRVS hit a ceiling of 0.14% in Q3 2025 and a floor of 0.93% in Q4 2024.
  • Median Return on Assets over the past 4 years was 0.5% (2023), compared with a mean of 0.52%.
  • Biggest five-year swings in Return on Assets: plummeted -48bps in 2024 and later skyrocketed 74bps in 2025.
  • Corvus Pharmaceuticals' Return on Assets stood at 0.44% in 2022, then fell by -2bps to 0.45% in 2023, then plummeted by -107bps to 0.93% in 2024, then skyrocketed by 85bps to 0.14% in 2025.
  • The last three reported values for Return on Assets were 0.14% (Q3 2025), 0.56% (Q2 2025), and 0.58% (Q1 2025) per Business Quant data.